Skip to content

Patterns of polydrug use among ketamine injectors in New York City.

Stephen E Lankenau, Michael C Clatts

Substance Use & Misuse 2005 DOI: 10.1081/ja-200066936 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Ethno-epidemiological qualitative study Peer reviewed
Sample size 40
Population Young ketamine injectors under 25 years old in New York
Interventions Ketamine marijuana alcohol PCP speed
Topics Esketamine Ketamine
Key findings Ketamine was typically injected or sniffed during polydrug-using events, most commonly with marijuana, alcohol, PCP, and speed. The sequencing of drug use, drug combinations, drug forms, and routes of administration varied widely across events. The authors argue that future research should more comprehensively describe risks of combining ketamine with other drugs, including overdose, bloodborne pathogen transmission such as HIV and HCV, and cognitive effects.

Abstract

Polydrug use is an important public health issue since it has been linked to significant adverse health outcomes. Recently, club drugs, including ketamine and other drugs used in dance/rave scenes, have been identified as key substances in new types of polydrug using patterns. While seemingly a self-explanatory concept, "polydrug" use constitutes multiple drug using practices that may impact upon health risks. Ketamine, a club drug commonly administered intranasally among youth for its disassociative properties, has emerged as a drug increasingly prevalent among a new hidden population of injection drug users (IDUs). Using an ethno-epidemiological methodology, we interviewed 40 young (<25 years old) ketamine injectors in New York during 2000-2002 to describe the potential health risks associated with ketamine and polydrug use. Findings indicate that ketamine was typically injected or sniffed in the context of a polydrug using event. Marijuana, alcohol, PCP, and speed were among the most commonly used drugs during recent ketamine using events. Polydrug using events were often quite variable regarding the sequencing of drug use, the drug combinations consumed, the forms of the drug utilized, and the modes of administrating the drug combinations. Future research should be directed towards developing a more comprehensive description of the risks associated with combining ketamine with other drugs, such as drug overdoses, the transmission of bloodborne pathogens, such as HIV and HCV, the short- and long-term effects of drug combinations on cognitive functioning, and other unanticipated consequences associated with polydrug use.

Comparable studies

Other qualitative studies on ketamine, most cited first.

Study Year Design Participants
Ketamine for Depression, 4: In What Dose, at What Rate, by What Route, for How Long, and at What Frequency? 2017 Qualitative review
Holding on or letting go? Patient experiences of control, context, and care in oral esketamine treatment for treatment-resistant depression: A qualitative study. Patients with treatment-resistant depression participating in off-label oral esketamine... 2022 Qualitative study n = 17
A Cohort-Based Case Report: The Impact of Ketamine-Assisted Therapy Embedded in a Community of Practice Framework for Healthcare Providers With PTSD and Depression Healthcare providers 2022 Quality improvement evaluation with mixed methods n = 94
Predictors of Psychedelic Experience: A Thematic Analysis First-person reports of psychedelic use from the Erowid database (six reports each for... 2022 Thematic analysis n = 22
Expert Opinion on Psychedelic-Assisted Psychotherapy for People with Psychopathological Psychotic Experiences and Psychotic Disorders Experts in psychiatry, clinical psychology, medicine, and psychedelic effects 2024 Qualitative study n = 12

Citations in the library

Explore topics